DR. VLADIMIR VLADIMIROVICH BEREZIN
GENERAL MANAGER, DRG BIOMED OOO
Dr. Vladimir Vladimirovich Berezin is the General Manager of DRG Biomed, strategically located in Saint Petersburg, Russia and is a wholly-owned subsidiary of DRG International, Inc.
DRG Biomed serves approximately 50 million people across the Northwestern section of Russia, and other regions including Altayiskii, Ekaterinburg, and Blagoveschensk.
Vladimir is responsible for DRG Biomed’s business activity, including supplying and equipping various medical institutions with DRG ELISA Diagnostic kits and vendor equipment (including GE, ITC, Stereotaxis,CryoCath-Medtronic, etc.). These supplies help fulfill the needs of various medical institutions’ departments, including cardiology, functional diagnostics, Cath and EP labs, operating rooms, laboratories, intensive care units and x-ray diagnostics.
DRG Biomed is part of the DRG International group of companies. Including DRG Biomed, the DRG International Group is active in more than 110 countries. The Company continues to expand its multinational presence by producing and distributing innovative specialty clinical diagnostics and medical equipment. In 1997, Vladimir began working at DRG in St. Petersburg as a manager while attending classes as the Stockholm School of Economics located in St. Petersburg. Vladimir went on to earn his MBA and continued his aspirations towards higher education by achieving his Ph.D. in Psychological Education at St. Petersburg University.
Vladimir graduated from Leningrad Medical University in 1988.
From 1988 until 1997, Vladimir worked as a cardiologist at hospitals in close proximity to St. Petersburg’s Medical University, such as the St. Petersburg Regional Hospital among others.
In his spare time, Dr. Berezin enjoys spending time with his wife and 19-year old daughter, also a student of St. Petersburg Medical University. His hobbies include snowboarding and mountain skiing.
News and Updates
On June 4th-6th, the DRG:HYBRiD-XL Summer workshop took place in Germany with distributors from Nepal, Lebanon, and Australia. It was a very enthusiastic group! Key topics discussed included real situations in the field and Hepcidin as a new biomarker. Attendees...
DRG is proud to announce the launch of a NEW assay kit as part of DRG's Iron Panel: sTfR ELISA RUO (EIA-5925R).Specifications of the new assay kit sTfR ELISA RUO, EIA-5925R:Principle of the Assay: ELISA based on the sandwich principleAssay Range: 0.145 – 160...
DRG is proud to announce the launch of a NEW and UNIQUE assay kit of DRG's Iron Panel: Salivary Hepcidin RUO (SLV-6082R).The hormone hepcidin plays an important role in regulating iron metabolism. It is a major regulator of dietary iron absorption and iron...